Nurix Therapeutics, Inc. (NRIX) vs Intellia Therapeutics, Inc. (NTLA)

• Nurix Therapeutics, Inc. NRIX 15.30 ▲ +3.10%
• Intellia Therapeutics, Inc. NTLA 11.35 ▲ +2.25%

Nurix Therapeutics, Inc. and Intellia Therapeutics, Inc. are both Biotechnology companies. Nurix Therapeutics, Inc. and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Intellia Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 6.1×. Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: 738.8% against −8.07%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −805.8%) and the higher return on invested capital (0.00% vs −195.3%). Across the 16 metrics below, Nurix Therapeutics, Inc. leads on 14 and Intellia Therapeutics, Inc. on 2.